NCT06658119 Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled Trial
| NCT ID | NCT06658119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Cataract |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-12-15 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-12-15 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the clinical outcomes of two extended depth-of-focus intraocular lens after cataract surgery. The randomized controlled trail will enroll 90 participants. The participants will be randomly assigned to implant Tecnis Synergy ZFR00 or Tecnis Symfony ZXR00 intraocular lens. Follow-up visit will be performed till 3 months postoperatively to compare the visual acuity, subjective manifest refraction, and visual quality between groups.
Eligibility Criteria
Inclusion Criteria: * age-related cataract patients aged between 40 to 80 * patients with preoperative astigmatism less than 0.75 D, and kappa value less than 0.7 mm * patients who plan to receive femtosecond laser-assisted cataract surgery Exclusion Criteria: * patients with ocular surface abnormalities such as irregular corneal astigmatism, corneal scarring, keratoconus, and pterygium) * patients with history of ocular trauma or surgery * patients with coexisting ocular disorders such as glaucoma, retinal vascular occlusive disease, retinal detachment, diabetic retinopathy, and any optic nerve-related pathologies * patients with concurrent severe systemic diseases * patients who lack of cooperation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06658119 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Cataract. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06658119 currently recruiting?
Yes, NCT06658119 is actively recruiting participants. Contact the research team at yyzbzhong@zju.edu.cn for enrollment information.
Where is the NCT06658119 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06658119 clinical trial?
NCT06658119 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 90 participants.